Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Dexamethasone for AKI Prevention in Cardiac Surgery
NCT06783634Phase 1Recruiting
- Sponsor
- Ain Shams University
- Start
- Feb 2025
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexamethasone in acute kidney injury (AKI) (2 arms), sponsored by Ain Shams University. Primary endpoint: Postoperative Acute Kidney Injury at 7 days. Started Feb 2025; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06783634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06783634.